FOI release

Neulasta: FOI Request

This request was refused in part, so we didn't provide some of the information the requester asked for. This may include information where we can neither confirm nor deny that we hold it.

Case reference FOI2026/00787

Received 20 July 2026

Published 7 September 2026

Request

Please can you provide a copy of the current, approved Risk Management Plan for the following product: Product details: Neulasta 6 mg solution for injection Active substance: pegfilgrastim MA Number: PLGB 13832/0033 MAH: Amgen Ltd

Response

See attached

Documents

• FOI2026_00787 (redacted).pdf (544.4 KB)
• Neulasta RMP (redacted).pdf (16.4 MB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.